TP53 and osteosarcoma: The risk of osteosarcoma is almost 1000 times higher for patients with germline mutations in RB, and the same is true for patients with Li–Fraumeni syndrome (germline p53 mutation), who also exhibit a markedly higher incidence of this tumour [6].